Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01827 |
| Species: | Homo sapiens |
| Position : | chr15:40931917-40933388 |
| Year: | 2022 |
| Title: | The Tumor Invasion Paradox in Cancer Stem Cell-Driven Solid Tumors |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | T-cell acute lymphoblastic leukemia |
| PMID: | 36301402 |
| MONDO: | MONDO:0004947 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Jurkat |
| CVCL ID: | CVCL_0065 |
| Cell Type: | T lymphoblast |
| Cell Ontology ID: | CL:0002419 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | Hi-C, ATAC-seq, CUT&Tag, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPRi, RT-RT-qPCR |
| Target gene : | NSMCE3 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|